Categories
I-CARE Early Covid (187)
I-CARE Flu and RSV (36)
I-PREVENT (153)
I-RECOVER Long Covid (111)
I-RECOVER Post-Vaccine (320)
MATH+ (198)
Tags
ACE2 protein (10)
acute respiratory distress syndrome (14)
Alopecia (7)
Anti-inflammatory (9)
Antidepressants (9)
Ascorbic Acid (12)
autoantibodies (10)
autophagy (24)
Calcifediol (6)
Cancer (9)
Corticosteroids (9)
COVID-19 (270)
COVID-19 Vaccines (8)
Curcumin (8)
Cytokines (12)
Depression (10)
Famotidine (14)
flavonoids (5)
Glucocorticoids (7)
Hydroxychloroquine (12)
Hyperbaric Oxygen Therapy (9)
Inflammation (14)
ivermectin (47)
long COVID (21)
Mast Cells (8)
Melatonin (20)
Methylprednisolone (7)
molnupiravir (5)
N-Acetylcysteine (6)
Non-Invasive Brain Stimulation (8)
Omicron (7)
Oxytocin (8)
Pneumonia (8)
quercetin (15)
SARS-CoV-2 (72)
SARS-CoV-2 mRNA Vaccines (7)
Sepsis (18)
spermidine (11)
Spike Protein (10)
Thiamine (7)
Thrombosis (9)
Tinnitus (12)
Vitamin C (28)
Vitamin D (10)
Zinc (12)
Authors: Usami O, Saitoh H, Ashino Y, Hattori T PMID: 23337623 DOI: 10.1620/tjem.229.137 Abstract Acyclovir is known for its antiviral activity against some pathogenic viruses such as the Epstein-Barr virus (EBV) that causes infectious mononucleosis (IM) and IM-like illness. Therefore, we empirically administered acyclovir to patients with suspected EBV-IM and IM like-illness, upon their admission [...]
Categories: I-RECOVER Post-Vaccine
Tags: Acyclovir
